ZYVET ANIMAL HEALTH
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 16 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97595104
- Mark type
- Design + words
- Filed
- 16 Sept 2022
- Published for opposition
- 08 Aug 2023
- Attorney of record
- Anthony J. DiMarino
Goods and services
- Class 005 — Pharmaceuticals: Prescription and over-the-counter pharmaceutical preparations for use with animals for the treatment of seizures, separation anxiety, personality disorders, epilepsy, certain infectious or parasitic diseases, neoplasms, diseases of the blood or blood-forming organs, diseases of the immune system, endocrine, nutritional or metabolic diseases, mental, behavioral or neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the visual system, disease of the ear or mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin, diseases of the musculoskeletal system or connective tissue, diseases of the genitourinary system, conditions related to sexual health, pregnancy, childbirth or the puerperium, certain conditions originating in the perinatal period, developmental anomalies, systems, signs or clinical findings, not elsewhere classified, external causes of morbidity or mortality, and injury, poisoning or certain other consequences of external causes; dietary and nutritional supplements for animals; Medicated supplements for foodstuffs for animals; dietary preparations for animals, namely, feeding stimulants, probiotic animal feed, preparations to prevent chewing or biting by animals, preparations for the treatment of a variety of illnesses and health conditions in domestic animals and livestock, preparations for the treatment of post-surgical recovery, recovery from dental procedures, pharmaceutical side effects, and stress-related and intestinal illnesses and health conditions in domestic animals and livestock, preparations for assisting in the maintenance of health, energy and nutritional wellness of domestic animals and livestock, Certain infectious or parasitic diseases; diseases of the immune system; diseases of the nervous system; diseases of the respiratory system; diseases of the digestive system; diseases of the skin; diseases of the musculoskeletal system or connective tissue; systems, signs or clinical findings, not elsewhere classified; preparations to prevent chewing or biting by animals; preparations for the treatment of a variety of illnesses and health conditions in domestic animals and livestock; preparations for the treatment of post-surgical recovery; recovery from dental procedures, pharmaceutical side effects, and stress-related and intestinal illnesses and health conditions in domestic animals and livestock; preparations for assisting in the maintenance of health, energy and nutritional wellness of domestic animals and livestock; preparations for assisting in the maintenance of digestive, immune, circulatory, and reproductive systems in domestic animals and livestock; preparations to treat or prevent fleas and ticks, and the eggs of these insects, on pets
Owner
- ZyVet Animal Health Inc., Pennington, NJ, US
- ZyVet Animal Health Inc., Pennington, NJ, US
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Mar 2026 — AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
- 10 Mar 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 11 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Sept 2025 — USE AMENDMENT FILED
- 10 Feb 2026 — SOU EXTENSION 4 GRANTED
- 17 Sept 2025 — SOU EXTENSION 4 FILED
- 06 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 26 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Mar 2025 — SOU EXTENSION 3 GRANTED
- 25 Mar 2025 — SOU EXTENSION 3 FILED